Transcriptomic effects of di-(2-ethylhexyl)-phthalate in Syrian hamster embryo cells: An important role of early cytoskeleton disturbances in carcinogenesis?

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Landkocz, Yann ^a   Poupin, Pascal ^a   Atienzar, Franck ^b   Vasseur, Paule ^a  

^a Nancy University   (France)

^b UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; TRANSCRIPTOME; ACTIN BINDING PROTEIN; CORONIN PROTEINS; KINESIN; NEUROPILIN 2; PLASTICIZER;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL JUNCTION; CONTROLLED STUDY; CYP4 GENE; CYTOSKELETON; DOWN REGULATION; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PPARS GENE; PROTEIN CONFORMATION; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION; XENOBIOTIC METABOLISM; ANIMAL; ANIMAL EMBRYO; CARCINOGEN TESTING; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; METABOLISM;

MAMMALIA; MESOCRICETUS AURATUS;

ANIMALS; CARCINOGENICITY TESTS; CELLS, CULTURED; CRICETINAE; CYTOSKELETON; DIETHYLHEXYL PHTHALATE; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; KINESIN; MICROFILAMENT PROTEINS; NEUROPILIN-2; PLASTICIZERS; TRANSCRIPTOME;

EID: 80054847938     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-524     Document Type: Article

References (76)

1. Heudorf U, Mersch-Sundermann V, Angerer J. Phthalates: Toxicology and exposure. Int J Hyg Environ Health 2007, 210:623-634. 10.1016/j.ijheh.2007.07.011, 17889607.
2. Becker K, Göen T, Seiwert M, Conrad A, Pick-Fuss H, Müller J, Wittassek M, Schulz C, Kolossa-Gehring M. GerES IV: Phthalates metabolites and Bisphenol A in urine of German Children. Int J Hyg Environ Health 2009, 212(6):685-692. 10.1016/j.ijheh.2009.08.002, 19729343.
3. Nakajima T, Hopf NB, Schulte PA. IARC Di(2-ethylhexyl) phthalate (DEHP). IARC Monographs 2000, 77. IARC.
4. Sharpe RM. Hormones and testis development and the possible adverse effets on environmental chemicals. Toxicol Lett 2001, 120:221-232. 10.1016/S0378-4274(01)00298-3, 11323180.
5. Akingbemi BT, Ge R, Klinefelter GR, Zirkin BR, Hardy MP. Phthalate induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. Proc Natl Acad Sci USA 2004, 101:775-780. 10.1073/pnas.0305977101, 321757, 14715905.
6. Latini G, Verroti A, De Felice C. Di-ethylhexyl phthalate and endocrine disruption: a review. Curr Drug Targ 2004, 4:37-40.
7. Pan G, Hanaoka T, Yoshimura M, Zhang S, Wang P, Tsukino H, Inoue K, Nakazawa H, Tsugane S, Takahashi K. Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ Health Perspect 2006, 114:1643-1648. 1665432, 17107847.
8. Meeker JD, Calafat AM, Hauser R. Di-(ethylhexyl)phthalate metabolites may alter thyroid hormone levels in men. Environ Health Perspect 2007, 115(7):1029-1034. 10.1289/ehp.9852, 1913587, 17637918.
9. Melnick RL, Morrissey RE, Tomaszewski KE. Studies by the National Toxicology Program on di(2-ethylhexyl)phthalate. Toxicol Ind Health 1987, 3:99-118.
10. Lapinskas PJ, Brown S, Leesnitzer LM, Blanchard S, Swanson C, Cattley RC, Corton JC. Role of PPARα in mediating the effects of phthalates and metabolites in the liver. Toxicology 2005, 207:149-163. 10.1016/j.tox.2004.09.008, 15590130.
11. Feige JN, Gelman L, Rossi D, Zoete V, Métivier R, Tudor C, Anghel SI, Grosdidier A, Lathion C, Engelborghs Y, Michielin O, Wahli W, Desvergne B. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor γ modulator that promotes adipogenesis. J Biol Chem 2007, 282(26):19152-19166. 10.1074/jbc.M702724200, 17468099.
12. Erkekoǧlu P, Rachidi W, De Rosa V, Giray B, Favier A, Hincal F. Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells. Free Radic Biol Med 2010, 49(4):559-66. 10.1016/j.freeradbiomed.2010.04.038, 20466057.
13. Erkekoǧlu P, Rachidi W, Yüzügüll OG, Giray B, Oztürk M, Favier A, Hincal F. Induction of ROS, p53, p21 in DEHP- and MEHP-exposed LNCaP cells-protection by selenium compounds. Food Chem Toxicol 2011, 49(7):1565-1571. 10.1016/j.fct.2011.04.001, 21515331.
14. Erkekoǧlu P, Rachidi W, Yüzügüll OG, Giray B, Favier A, Oztürk M, Hincal F. Evaluation of cytotoxicity and oxidative DNA damaging effects of di(2-ethylhexyl)-phthalate (DEHP) and mono(2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and protection by selenium. Toxicol Appl Pharmacol 2010, 248(1):52-62. 10.1016/j.taap.2010.07.016, 20659492.
15. Doull J, Cattley R, Elcombe C, Lake B, Swenberg J, Wilkinson C, Williams G, van Gemert M. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the New U.S. EPA Risk Assessment Guidelines. Regul Toxicol Pharmacol 1999, 29:327-357. 10.1006/rtph.1999.1296, 10388618.
16. Voss C, Zerban H, Bannasch P, Berger MR. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver ans testes of Sprague-Dawley rats. Toxicology 2005, 206(3):359-371. 10.1016/j.tox.2004.07.016, 15588926.
17. David RM, Moore MR, Finney DC, Guest D. Chronic toxicity of di(2-ethylhexyl)phthalate in rats. Toxicol Sci 2000, 55:433-443. 10.1093/toxsci/55.2.433, 10828276.
18. Melnick RL. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?. Environ Health Perspect 2001, 109:437-442. 10.1289/ehp.01109437, 1240301, 11401753.
19. Ito Y, Yamanoshita O, Asaeda N, Tagawa Y, Lee CH, Aoyama T, Ichihara G, Furuhashi K, Kamijima M, Gonzalez FJ, Nakajima T. Di(2-ethylhexyl)phthalate induces hepatic tumorigenesis through a peroxisome proliferator-activated receptor α-independent pathway. J Occup Health 2007, 49:172-182. 10.1539/joh.49.172, 17575397.
20. Ren H, Aleksunes LM, Wood C, Vallanat B, George MH, Klaassen CD, Corton JC. Characterization of peroxisome proliferator-activated receptor α-independent effect of PPARα activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor. Tox Sci 2010, 113(1):45-59.
21. Roberts RA. Evidence of cross talk between PPARα and p38 MAP Kinase. Tox Sci 2002, 68:270-274.
22. Ito Y, Nakajima T. PPARα- and DEHP-induced cancers. PPAR Res 2008, 1-12.
23. Cruciani V, Rast C, Durant MJ, Alexandre S, Nguyen-Ba G, Vasseur P. Morphological transformation and inhibition of intercellular communication of Syrian hamster embryo cells by hepatic peroxisome proliferators. Mutat Res Fundam Mol Mech Mut 1997, 379(Suppl 1):S195.
24. James NH, Roberts RA. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis. Carcinogenesis 1996, 17(8):1623-1632. 10.1093/carcin/17.8.1623, 8761418.
25. Roberts RA, James NH, Hasmall SC, Holden PR, Lambe K, Macdonald N, West D, Woodyatt NJ, Whitcome D. Apoptosis and proliferation in non-genotoxic carcinogenesis: species differences and role of PPARα. Toxicol Lett 2000, 112-113:49-57.
26. Maire MA, Rast C, Vasseur P. Di-(ethylhexyl)phthalate (DEHP) increases Bcl-2/Bax ratio and modifies c-myc expression in Syrian hamster embryo (SHE) cells. Toxicol Lett 2005, 158(3):237-245. 10.1016/j.toxlet.2005.04.004, 15923092.
27. Mikalsen SO, Holen I, Sanner T. Morphological transformation and catalase activity of Syrian hamster embryo cells treated with hepatic peroxisome proliferators, TPA and nickel sulphate. Cell Biol Toxicol 1990, 6(1):1-14. 10.1007/BF00135022, 2334865.
28. LeBoeuf RA, Kerckaert GA, Aardema MJ, Gibson DP, Brauninger R, Isfort RJ. The pH 6.7 Syrian hamster embryo cell transformation assay assessing the carcinogenic potential of chemicals. Mutat Res 1996, 356(1):85-127. 10.1016/0027-5107(95)00199-9, 8841476.
29. Cruciani V, Rast C, Alexandre S, Nguyen-Ba G, Vasseur P. Peroxisome proliferator-induced transformation of Syrian hamster embryo cells: influence of experimental procedures. Toxicol In Vitro 1999, 13:445-457. 10.1016/S0887-2333(99)00016-8, 20654502.
30. Alexandre S, Rast C, Maire MA, Orfila L, Vasseur P. ZnCl2 induces Syrian hamster embryo (SHE) cell transformation. Toxicol Lett 2003, 143:77-87.
31. Isfort RJ, Kerckaert G, Anderson NL, LeBoeuf RA. Two-dimensional gel electrophoresis analysis of Syrian hamster embryo cells: morphological transformation is not cell type specific. Electrophoresis 1992, 13(11):855-861.
32. Berwald Y, Sachs L. In vitro cell transformation with chemicals carcinogens. Nature 1963, 200:1182-1184. 10.1038/2001182a0, 14089903.
33. Combes R, Balls M, Curren R, Fischbach M, Fusenig N, Kirkland D, Lasne C, Landolph J, LeBoeuf R, Marquardt H, McCormick J, Müller L, Rivedal E, Sabbioni E, Tanaka N, Vasseur P, Yamasaki H. Cell transformation assays as predictors of human carcinogenicity. The report and recommendations of ECVAM Workshop XX 1999, 27:745-767. Balls M, ATLA.
34. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992, 257:967-971. 10.1126/science.1354393, 1354393.
35. Liang P, Meade JD, Pardee AB. A protocol for differential display of mRNA expression using either fluorescent or radioactive labelling. Nat Prot 2007, 2(3):457-470.
36. Liang P, Pardee AB. Recent advances in differential display. Curr Opin Immunol 1995, 7:274-280. 10.1016/0952-7915(95)80015-8, 7546389.
37. Pollack R, Osborn M, Weber K. Patterns of organization of actin and myosin in normal and transformed cultured cells. Proc Nat Acad Sci USA 1975, 72(3):994-998. 10.1073/pnas.72.3.994, 432450, 165499.
38. Posnack NG, Lee NH, Brown R, Sarvazyan N. Gene expression profiling of DEHP-treated cardiomyocytes reveals potential causes of phthalate arrhythmogenicity. Toxicology 2011, 279:54-64. 10.1016/j.tox.2010.09.007, 20920545.
39. Lambrechts A, Van Troys M, Ampe C. The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol 2004, 26:1890-1909.
40. Rosentreter A, Hofmann A, Xavier CP, Stumpf M, Noegel AA, Clemen CS. Coronin 3 involvement in F-actin-dependent processes at the cell cortex. Exp Cell Res 2007, 313:878-895. 10.1016/j.yexcr.2006.12.015, 17274980.
41. Weed SA, Parsons JT. Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 2001, 20:6418-6434. 10.1038/sj.onc.1204783, 11607842.
42. Daly RJ. Cortactin signalling and dynamic actin networks. Biochem J 2004, 382:13-25. 1133910, 15186216.
43. Tran TC, Singleton C, Fraley TS, Greenwood JA. Cystein-rich protein 1 (CRP1) regulates actin filament bundling. BMC Cell Biol 2005, 6:45. 10.1186/1471-2121-6-45, 1318456, 16336664.
44. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004, 4(2):118-132. 10.1038/nrc1276, 14964308.
45. Samarin SN, Koch S, Ivanov AI, Parkos CA, Nusrat A. Coronin 1C negatively regulates cell-matrix adhesion and motility of intestinal epithelial cells. Biochem Biophys Res Commun 2010, 391(1):394-400. 10.1016/j.bbrc.2009.11.069, 2812594, 19913511.
46. Nishida Y, Knudson W, Knudson CB, Ishiguro N. Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity. Exp Cell Res 2005, 307:194-203. 10.1016/j.yexcr.2005.03.026, 3182490, 15922739.
47. Chandrasekaran S, Guo NH, Rodrigues RG, Kaiser J, Roberts DD. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by α3β1 integrin and regulated insulin-like growth factor-1 and CD98. J Biol Chem 1999, 274(16):11408-11416. 10.1074/jbc.274.16.11408, 10196234.
48. Kwiatkowski AV, Gertler FB, Loureiro JJ. Function and regulation of Ena/VASP proteins. Trends Cell Biol 2003, 13:386-392. 10.1016/S0962-8924(03)00130-2, 12837609.
49. Lacy SE, Bönnemann CG, Buzney EA, Kunkel LM. Identification of FLRT1, FLRT2 and FLRT3: A novel family of transmembrane leucine-rich repeat proteins. Genomics 1999, 62:417-426. 10.1006/geno.1999.6033, 10644439.
50. Kohfeldt E, Sasaki T, Göhring W, Timpl R. Nidogen-2: A new basement membrane protein with diverse binding properties. J Mol Biol 1998, 282:99-109. 10.1006/jmbi.1998.2004, 9733643.
51. Barker TH, Grenett HE, MacEwen MW, Tilden SG, Fuller GM, Settleman J, Woods A, Murphy-Ullrich J, Hagood JS. Thy-1 regulates fibroblast focal adhesion, cytoskeletal organization and migration through modulation of p190 ThoGAP and Rho GTPase activity. Exp Cell Res 2004, 295:488-496. 10.1016/j.yexcr.2004.01.026, 15093746.
52. Rege TA, Hagood JS. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J 2006, 20:1045-1054. 10.1096/fj.05-5460rev, 16770003.
53. Sobarzo CM, Lustig L, Ponzio R, Denduchis B. Effect of di-(2-ethylhexyl)phthalate on N-cadherin and catenin protein expression in rat testis. Reprod Tox 2006, 22:77-86.
54. Bielenberg DR, Pettaway CA, Takashima S, Klagsbrun M. Neuropilins in neoplasms: expression, regulation, and function. Exp Cell Res 2006, 312:584-593. 10.1016/j.yexcr.2005.11.024, 16445911.
55. Worby CA, Dixon JE. Sorting out the cellular functions of sorting nexins. Nat Rev Mol Cell Biol 2002, 3:919-931. 10.1038/nrm974, 12461558.
56. Öklu R, Hesketh R. The latent transforming growth factor β binding protein (LTBP) family. Biochem J 2000, 352:601-610. 10.1042/0264-6021:3520601, 1221494, 11104663.
57. Zhou ZQ, Cao WH, Xie JJ, Lin J, Shen ZY, Zhang QY, Shen JH, Xu LY, Li EM. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer 2009, 9:291-299. 10.1186/1471-2407-9-291, 2748090, 19698122.
58. Lin PT, Gleeson JG, Corbo JC, Flanagan L, Walsh CA. DCAMKL1 encodes a protein kinase with homology to doublecortin that regulates microtubule polymerization. J Neurosci 2000, 20(24):9152-9161.
59. Hai CM, Gu Z. Caldesmon phosphorylation in actin cytoskeletal remodeling. Eur J Cell Biol 2006, 85:305-309. 10.1016/j.ejcb.2005.08.008, 16546574.
60. Wang Q, Symes AJ, Kane CA, Freeman A, Nariculam J, Munson P, Thrasivoulou C, Masters JR, Ahmed A. A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancer. PloS One 2010, 5(5):1-11.
61. Bennett RD, Strehler EE. Calmodulin-like protein enhances myosin-10 translation. Biochem Biophys Res Commun 2008, 369:654-659. 10.1016/j.bbrc.2008.02.056, 18295593.
62. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, Driscoll PC, Woscholski R, Parker PJ, Waterfield MD. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001, 70:535-602. 10.1146/annurev.biochem.70.1.535, 11395417.
63. Reif S, Lang A, Lindquist JN, Yata Y, Gäbele E, Scanga A, Brenner DA, Rippe RA. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stallate cell proliferation and type I collagen expression. J Biol Chem 2003, 278(10):8083-8090. 10.1074/jbc.M212927200, 12502711.
64. Espada J, Galaz S, Sanz-Rodríguez F, Blázquez-Castro A, Stockert JC, Bagazgoitia L, Jaén P, González S, Cano A, Juarranz A. Oncongenic H-Ras and PI3K signaling can inhibit E-Cadherin-dependent apoptosis and promote cell survival after photodynamic therapy in mouse keratinocytes. J Cell Physiol 2009, 219:84-93. 10.1002/jcp.21652, 19065634.
65. Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, Liu-Mares W, Rider DN, Vachon CM, Cerhan JR, Olson JE, Couch FJ. Association of genetic variation in genes implicated in the β-Catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2008, 17(8):2101-2108. 10.1158/1055-9965.EPI-08-0134, 2771409, 18708403.
66. Bell DR, Elcombe CR. Induction of Acyl-Coa oxidase and Cytochrome-P450iva1 Rna in rat primary hepatocyte culture by peroxisome proliferators. Biochem J 1991, 280:249-253. 1130627, 1720616.
67. Eveillard A, Mselli-Lakhal L, Mogha A, Lasserre F, Polizzi A, Pascussi JM, Guillou H, Martin PGP, Pineau T. Di-(2-ethylhexyl)-phthalate (DEHP) activates the constitutive androstane receptor (CAR): a novel signalling pathway sensitive to phthalates. Biochem Pharmacol 2009, 77:1735-1746. 10.1016/j.bcp.2009.02.023, 19428328.
68. Eveillard A, Lasserre F, de Tayrac M, Polizzi A, Claus S, Canlet C, Mselli-Lakhal L, Gotardi G, Paris A, Guillou H, Martin PGP, Pineau T. Identification of potential mechanisms of toxicity after di-(2-ethylhexyl)-phthalate (DEHP) adult exposure in the liver using a system biology approach. Tox App Pharmacol 2009, 236:282-292.
69. Lake BG, Rumsby PC, Price RJ, Cunninghame ME. Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta 1 gene expression in the rat, Syrian hamster and guinea pig. Mutat Res Fundam Mol Mech Mut 2000, 448:213-225.
70. Takashima K, Ito Y, Gonzalez FJ, Nakajima T. Different mechanisms of DEHP-induced hepatocellular adenoma tumorigenesis in Wild-type and Pparα-null mice. J Occup Health 2008, 50:169-180. 10.1539/joh.L7105, 18403868.
71. Quinn JA, Graeber T, Frackelton AR, Kim M, Schwarzbauer JE, Filardo EJ. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by G protein-coupled receptor, GPR30. Endocrinology 2009, 23:1052-1064.
72. Prossnitz ER, Barton M. Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prostaglandins Other Lipid Mediat 2009, 89(3-4):89-97. 10.1016/j.prostaglandins.2009.05.001, 2740807, 19442754.
73. Kleuser B, Malek D, Gust R, Pertz HH, Potteck H. 17-β-estradiol inhibits transforming growth factor-β signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase throught the G protein-coupled receptor 30. Mol Pharmacol 2008, 74:1533-1543. 10.1124/mol.108.046854, 18768737.
74. Pienta RJ, Poiley JA, Lebherz WB. Morphological transformation of early passage golden Syrian hamster embryo cells derived from cryopreserved primary cultures as a reliable in vitro bioassay for identifying diverse carcinogens. Int J Cancer 1977, 19:642-655. 10.1002/ijc.2910190508, 863543.
75. Elias Z, Poirot O, Daniere MC, Terzetti F, Marande AM, Dzwigaj S, Pezerat H, Fenoglio I, Fubini B. Cytotoxic and transforming effects of silica particles with different surface properties in Syrian hamster embryo (SHE) cells. Toxicol In Vitro 1989, 14:409-422.
76. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.